Do Bio-Identical Hormones have the same danger of breast cancer as other forms of hormone replacement therapy?
Bio-Identical Hormones act differently in the body than do synthetic hormones. Age and family history are very significant risk factors that play into the decision of whether to use Bio-Identical Hormones. In some studies, Bio-Identical Hormones do not carry with them the same risk of breast cancer as high doses of oral estrogens that do not maintain the correct estrogen ratio or hormone metabolites. Nor do they increase the risk of breast cancer like the synthetic, chemical progestins used in the Women’s Health Initiative Trial. The age of the woman when BHRT is used is an important factor. Side effects and health concerns increase as the time from menopause increases. BHRT should not be used indefinitely as some kind of fountain of youth. European medical studies suggest that bio-identical hormones may be safer than synthetic versions. But we must be cautious here, because they have not been well studied, especially for long-term use. And in any case, we recommend that women never th
